Intranasal administration delivers peptoids to the rat central nervous system
β Scribed by Tinna M. Ross; Ronald N. Zuckermann; Christoph Reinhard; William H. Frey II
- Book ID
- 116770441
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 558 KB
- Volume
- 439
- Category
- Article
- ISSN
- 0304-3940
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The blood-brain barrier (BBB) limits the distribution of systemically administered therapeutics to the central nervous system (CNS), posing a significant challenge to drug development efforts to treat neurological and psychiatric diseases and disorders. Intranasal delivery is a noninvasive and conve
The blood-brain barrier (BBB) limits the distribution of systemically administered therapeutics to the central nervous system (CNS). Intranasal delivery is a noninvasive method that targets drugs to the brain and spinal cord along olfactory and trigeminal neural pathways, bypassing the BBB and minim